2017
DOI: 10.1016/j.jemep.2017.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Protecting public health or commercial interests? The importance of transparency during immunization campaigns

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“… 22 ). As discussed by the Royal Society DELVE Initiative ( 19 ) this entails a commitment to “not hide the potential limitations of vaccines, including possible limited availability, incomplete protection requiring boosting and reactogenicity,” even if “such negative or complicating factors might lower uptake” as “their discovery post-rollout is likely to have a far greater negative impact on uptake.” Importantly, these current calls resonate with a number of critiques of the lack of transparency in prior but smaller-scale immunization campaigns ( 23 25 ).…”
mentioning
confidence: 93%
“… 22 ). As discussed by the Royal Society DELVE Initiative ( 19 ) this entails a commitment to “not hide the potential limitations of vaccines, including possible limited availability, incomplete protection requiring boosting and reactogenicity,” even if “such negative or complicating factors might lower uptake” as “their discovery post-rollout is likely to have a far greater negative impact on uptake.” Importantly, these current calls resonate with a number of critiques of the lack of transparency in prior but smaller-scale immunization campaigns ( 23 25 ).…”
mentioning
confidence: 93%
“…Institutions must ensure that public health research is conducted in an ethical and responsible manner, and that good research does not come at the expense of the protection of privacy. In so doing, by being transparent, institutions demonstrate that they are accountable and working in the public interest; they are trustworthy because they demonstrate that they have nothing to hide [32].…”
Section: Resultsmentioning
confidence: 99%
“…As discussed by The Royal Society DVELE Initiative (2020) this entails a commitment to "not hide the potential limitations of vaccines including possible limited availability, incomplete protection requiring boosting and reactogenicity", even if "such negative or complicating factors might lower uptake" as "their discovery post-rollout is likely to have a far greater negative impact on uptake." Importantly, these current calls resonate with a number of critiques of the lack of transparency in prior but smaller-scale immunization campaigns (Black & Rappuolli, 2010;Bélisle-Pipon et al, 2017;Dayrit et al, 2020).…”
mentioning
confidence: 88%